长春百克生物科技股份公司 关于将部分暂时闲置募集资金以定期存款方式存放的公告

Core Viewpoint - Changchun Baike Biological Technology Co., Ltd. plans to deposit a maximum of RMB 150 million of temporarily idle raised funds in fixed-term deposits to enhance fund utilization efficiency and increase returns for the company and its shareholders [1][3][4]. Fundraising Basic Situation - The company raised a total of RMB 1,500,675,944.50 through the public offering of 41,284,070 shares at a price of RMB 36.35 per share, with a net amount of RMB 1,395,794,418.15 after deducting various fees [1][2]. Purpose of Fund Deposit - The purpose of depositing the idle funds is to improve the efficiency of fund usage while ensuring that it does not affect the implementation of investment projects and the safety of the raised funds [3][4]. Deposit Details - The maximum amount to be deposited is RMB 150 million, with a usage period from October 24, 2025, to April 23, 2026, allowing for rolling use within this timeframe [4][6]. Implementation and Management - The board of directors has authorized the chairman or designated personnel to sign relevant legal documents, with the finance department responsible for organizing the implementation [6][9]. Information Disclosure - The company will comply with relevant regulations and timely fulfill information disclosure obligations, ensuring that the purpose of the raised funds remains unchanged [7][8]. Impact on Daily Operations - The plan to deposit idle funds will not affect the normal operation of the company's daily funds or the implementation of investment projects, ensuring no harm to the interests of the company and its shareholders [9][10]. Decision-Making Process - The board of directors approved the proposal during the ninth meeting of the sixth board on October 23, 2025, without needing to submit it to the shareholders' meeting [11][12].